+462.0%
MRNA vs ADVB
+2.9%
+459.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | ADVB | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.7% | +4.1% | -3.4% | +0.8% |
| 7D | -8.2% | -5.9% | -2.4% | -8.3% |
| 30D | +125.6% | +13.9% | +111.7% | +125.4% |
| 3M | +197.1% | +127.3% | +69.7% | +179.2% |
| 6M | +148.5% | +77.0% | +71.5% | +129.5% |
| YTD | +363.3% | +51.5% | +311.7% | +330.7% |
| 1Y | +462.0% | -11.3% | +473.3% | +466.5% |
| All | +462.0% | +2.9% | +459.1% | +466.5% |
Cumulative growth
Daily Returns
Daily percentage return beside ADVB.
Daily Out/Under-Performance
Portfolio return minus ADVB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ADVB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded ADVB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling